NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Patients with prostate cancer with:
-suspected metastasis who are candidates for initial definitive therapy
-suspected recurrence based on elevated serum prostate-specific antigen (PSA) level (i.e., a progressive and confirmed serum PSA level > 0.2 ng/mL)
-metastatic disease who might be candidates for treatment with 177Lu-labelled PSMA ligands
1 total trials
Filter these 1 trials by phase, country, sponsor and more.